Botanix Pharmaceuticals Limited Financials

Market Capitalization A$615.1 Million as of July 1, 2024

Valuations Metrics as of May. 5, 2024

Trailing PE
Forward PE
Price to Sales TTM	A$900.67
Price to Book MRQ	A$8.62
Enterprise to Revenue	842.77
Enterprise to EBITDA	-36.77

Financial Reports as of Jun. 30, 2023

Financials

Fiscal Year Ends	2023-06-30
Most Recent Quarter	2023-06-30
Profit Margin	0.00%
Operating Margin	-1462.26%
Return on Assets TTM	-18.33%
Return on Equity TTM	-32.25%

Income Statement

Revenue TTM	A$437,215
Revenue per Share TTM	A$0.00
Quarterly Revenue Growth	-89.80%
Gross Profit TTM	A$102,934
EBITDA	A$-10,021,756
Net Income to Common TTM	A$-10,024,153
Diluted EPS TTM	A$-0.01
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	A$18,313,360
Total Cash per Share MRQ	A$0.01
Total Debt MRQ	A$
Total Debt to Equity MRQ	0.00
Current Ratio MRQ	9.50
Book Value per Share MRQ	A$0.03

Cash Flow

Operating Cash Flow TTM	A$-10,103,973
Levered Free Cash Flow TTM	A$-22,116,324

BOT Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	1,575,139,968
Float Shares	1,304,815,377
Avg 10 Volume	2,721,524
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	16.23%
% Held by Institutions	9.80%

Stock Price Summary

Beta	1.84
Fifty Two Week Low	A$0.08
Fifty Two Week High	A$0.26
Fifty Two Week Change	66.80%
Day 50 MA	A$0.21
Day 200 MA	A$0.17

Dividends and Splits

Forward Annual Dividend Rate	A$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	A$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date	2016-06-16